Bioptamers

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Our personalized molecules are designed to specifically identify cancer cells and thus deliver precision therapeutic interventions. Our approach is based on the technology of aptamers, being efficient, scalable, and cheaper than those of other therapeutic classes such as monoclonal antibodies and antibody-drug conjugates, as also cellular and gene therapies
Speaker
photo
CEO
Bioptamers